glp-1 drugs with fewest side effects can cause pancreatitis, kidney injury, bowel obstruction, ministry warns There is a version of

Important conclusions drawn from recent meta-analyses involving over 300,000 patients report that while the retained gastric contents are significantly increased (fivefold to tenfold increase

Randomized controlled trials (RCTs) comparing insulin with established GLP-1 RAs, DPP-4is, or SGLT-2is were included

Considerations regarding adverse effects and contraindications for different drug classes are provided to help guide treatment decision-making when considering pharmacotherapy for weight management in patients with obesity.

Celine Gounder explains what this means for patients.

Jardiance is also approved to reduce the risk of hospitalization for heart failure in adults with or without diabetes